Log in

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

By MARI YAMAGUCHI
Posted 9/26/23

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies. It's the first drug for the treatment of the …

This item is available in full to subscribers.

Please log in to continue

Log in